Long-term suspension uterine perfusion agent for treating female animal postpartum infection and preparation process

Abstract

The invention discloses a long-term suspension uterine perfusion agent for treating female animal postpartum infection and a preparation process. The long-term suspension uterine perfusion agent comprises, by weight, 1.5-3.5kg of ofloxacin, 0.125-1kg of flunixin meglumine, 0.125-0.75kg of metronidazole, 0.125-1kg of leonurus extract (injection level), 0.125-1kg of angelica sinensis extract (injection level), 0.25-1.25kg of polyvinyl pyrrolidone (PVP)-K30, 2-15kg of polyethylene glycol (PEG)-400, 0.03kg of ethylene diamine tetraacetic acid (EDTA)-2Na and appropriate water for injection. The long-term suspension uterine perfusion agent is suitable for postpartum health care, is used for postpartum female animal preventive perfusion, effectively reduces morbidity of endometritism, remarkably shortens female animal estrus interval, and improves breeding success rate and farrowing rate of female animals. The long-term suspension uterine perfusion agent is injected in uterus by using an irrigator.

Description

technical field [0001] The invention relates to a long-acting suspension uterine perfusion agent for treating postpartum infection of female animals and a preparation process, belonging to the technical field of veterinary medicine. Background technique [0002] At present, with the increasing complexity of breeding diseases and the increasing potential pathogens and morbidity rates, in the clinical treatment of postpartum infectious diseases in female animals, intramuscular injection or oral administration is often used to solve postpartum infections. When the active ingredient of the medicine reaches the lesion site, it is greatly reduced, and the effect of complete cure cannot be achieved, which always causes the disease to be in a state of recessive infection. For this reason, we have developed a new prescription of long-acting suspension uterine perfusion agent for the prevention and treatment of postpartum infection in female animals. Preventive perfusion of postpartum...

AI Technical Summary

Problems solved by technology

[0002] At present, with the increasing complexity of breeding diseases and the increasing potential pathogens and morbidity rates, in the clinical treatment of postpartum infectious diseases in female animals, intramuscular injection or oral administration is often used to solve postpartum infections. When the active ingredients of the drug reach the lesion site, it will be greatly reduced, and the effect of complete cure will not be achieved, and the disease will always be in a state of recessive infection

Images